These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 34417894)

  • 1.
    Lindner T; Altmann A; Giesel F; Kratochwil C; Kleist C; Krämer S; Mier W; Cardinale J; Kauczor HU; Jäger D; Debus J; Haberkorn U
    EJNMMI Radiopharm Chem; 2021 Aug; 6(1):26. PubMed ID: 34417894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and Development of
    Lindner T; Altmann A; Krämer S; Kleist C; Loktev A; Kratochwil C; Giesel F; Mier W; Marme F; Debus J; Haberkorn U
    J Nucl Med; 2020 Oct; 61(10):1507-1513. PubMed ID: 32169911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A radiohybrid theranostics ligand labeled with fluorine-18 and lutetium-177 for fibroblast activation protein-targeted imaging and radionuclide therapy.
    Yang T; Peng L; Qiu J; He X; Zhang D; Wu R; Liu J; Zhang X; Zha Z
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2331-2341. PubMed ID: 36864362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an
    Toms J; Kogler J; Maschauer S; Daniel C; Schmidkonz C; Kuwert T; Prante O
    J Nucl Med; 2020 Dec; 61(12):1806-1813. PubMed ID: 32332144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical evaluation and pilot clinical study of [
    Ge L; Fu Z; Wei Y; Shi D; Geng Y; Fan H; Zhang R; Zhang Y; Li S; Wang S; Shi H; Song G; Pan J; Cheng K; Wang L
    Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4025-4036. PubMed ID: 35715613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [
    Wei Y; Zheng J; Ma L; Liu X; Xu S; Wang S; Pei J; Cheng K; Yuan S; Yu J
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2761-2773. PubMed ID: 35262766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and preclinical evaluation of novel
    Zhou H; Zhong J; Peng S; Liu Y; Tang P; Cai Z; Wang L; Xu H; Hu K
    Eur J Med Chem; 2024 Jan; 264():115993. PubMed ID: 38039792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visualization of Activated Fibroblasts in Heart Failure with Preserved Ejection Fraction with [
    Sun F; Wang C; Feng H; Yu F; Zhang X; Zhang P; Du X
    Mol Pharm; 2023 May; 20(5):2634-2641. PubMed ID: 37043243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [
    Wei Y; Cheng K; Fu Z; Zheng J; Mu Z; Zhao C; Liu X; Wang S; Yu J; Yuan S
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1671-1681. PubMed ID: 34870727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of [
    Liu N; Wan Q; Wu X; Zhao T; Jakobsson V; Yuan H; Chen X; Zhang J; Zhang W
    Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1685-1697. PubMed ID: 38246909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation and pilot clinical study of [
    Hu K; Li J; Wang L; Huang Y; Li L; Ye S; Han Y; Huang S; Wu H; Su J; Tang G
    Acta Pharm Sin B; 2022 Feb; 12(2):867-875. PubMed ID: 35256951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FAPI-04 PET/CT Using [
    Jiang X; Wang X; Shen T; Yao Y; Chen M; Li Z; Li X; Shen J; Kou Y; Chen S; Zhou X; Luo Z; Cheng Z
    Front Oncol; 2021; 11():649148. PubMed ID: 33816303
    [No Abstract]   [Full Text] [Related]  

  • 13. Noninvasive imaging of FAP expression using positron emission tomography: A comparative evaluation of a [
    Huang J; Fu L; Zhang X; Huang S; Dong Y; Hu K; Han Y; Zhou K; Min C; Huang Y; Tang G
    Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3363-3374. PubMed ID: 37266596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Fibroblast Activation Protein-Targeted Radiotracers with Improved Tumor Retention.
    Loktev A; Lindner T; Burger EM; Altmann A; Giesel F; Kratochwil C; Debus J; Marmé F; Jäger D; Mier W; Haberkorn U
    J Nucl Med; 2019 Oct; 60(10):1421-1429. PubMed ID: 30850501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.
    Röhrich M; Loktev A; Wefers AK; Altmann A; Paech D; Adeberg S; Windisch P; Hielscher T; Flechsig P; Floca R; Leitz D; Schuster JP; Huber PE; Debus J; von Deimling A; Lindner T; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2569-2580. PubMed ID: 31388723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automatic Production and Preliminary PET Imaging of a New Imaging Agent [
    Huang J; Fu L; Hu K; Huang S; Han Y; Lin R; Xu W; Tang G; Huang Y
    Front Oncol; 2021; 11():802676. PubMed ID: 35071007
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Li H; Ye S; Li Li ; Zhong J; Yan Q; Zhong Y; Feng P; Hu K
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2705-2715. PubMed ID: 35290473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA
    Moon ES; Elvas F; Vliegen G; De Lombaerde S; Vangestel C; De Bruycker S; Bracke A; Eppard E; Greifenstein L; Klasen B; Kramer V; Staelens S; De Meester I; Van der Veken P; Rösch F
    EJNMMI Radiopharm Chem; 2020 Jul; 5(1):19. PubMed ID: 32728930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAPI-74 PET/CT Using Either
    Giesel FL; Adeberg S; Syed M; Lindner T; Jiménez-Franco LD; Mavriopoulou E; Staudinger F; Tonndorf-Martini E; Regnery S; Rieken S; El Shafie R; Röhrich M; Flechsig P; Kluge A; Altmann A; Debus J; Haberkorn U; Kratochwil C
    J Nucl Med; 2021 Feb; 62(2):201-207. PubMed ID: 32591493
    [No Abstract]   [Full Text] [Related]  

  • 20. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.